| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone phosphatase activity | 4.95e-07 | 3 | 159 | 3 | GO:0140789 | |
| GeneOntologyMolecularFunction | histone H2AXY142 phosphatase activity | 4.95e-07 | 3 | 159 | 3 | GO:0140793 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | BIRC2 CCND1 PPP1R13L PARP14 DDX1 BCLAF3 YEATS2 ANKRD1 SUPT7L KDM2B MED17 SDR16C5 HSPA1A HSPA1B DNMT3A | 4.47e-05 | 562 | 159 | 15 | GO:0003712 |
| GeneOntologyMolecularFunction | chemokine activity | 5.25e-05 | 51 | 159 | 5 | GO:0008009 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | CCND1 PPP1R13L PARP14 YEATS2 ANKRD1 SDR16C5 HSPA1A HSPA1B DNMT3A | 9.41e-05 | 229 | 159 | 9 | GO:0003714 |
| GeneOntologyMolecularFunction | denatured protein binding | 1.88e-04 | 3 | 159 | 2 | GO:0031249 | |
| GeneOntologyMolecularFunction | 5-methylcytosine dioxygenase activity | 1.88e-04 | 3 | 159 | 2 | GO:0070579 | |
| GeneOntologyMolecularFunction | misfolded protein binding | 3.70e-04 | 18 | 159 | 3 | GO:0051787 | |
| GeneOntologyMolecularFunction | chemokine receptor binding | 4.73e-04 | 81 | 159 | 5 | GO:0042379 | |
| GeneOntologyMolecularFunction | alpha-amylase activity | 6.20e-04 | 5 | 159 | 2 | GO:0004556 | |
| GeneOntologyMolecularFunction | death receptor agonist activity | 6.20e-04 | 5 | 159 | 2 | GO:0038177 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | KLHDC2 BIRC2 CCND1 PPP1R13L PARP14 DDX1 FAN1 BCLAF3 YEATS2 RPTOR ANKRD1 SUPT7L SUN5 KDM2B MED17 SDR16C5 HSPA1A HSPA1B HOMER2 DNMT3A | 9.25e-04 | 1160 | 159 | 20 | GO:0030674 |
| GeneOntologyMolecularFunction | amylase activity | 9.25e-04 | 6 | 159 | 2 | GO:0016160 | |
| GeneOntologyMolecularFunction | ATP-dependent protein disaggregase activity | 9.25e-04 | 6 | 159 | 2 | GO:0140545 | |
| GeneOntologyMolecularFunction | C3HC4-type RING finger domain binding | 9.25e-04 | 6 | 159 | 2 | GO:0055131 | |
| GeneOntologyMolecularFunction | CCR chemokine receptor binding | 1.03e-03 | 56 | 159 | 4 | GO:0048020 | |
| GeneOntologyBiologicalProcess | negative regulation of signal transduction in absence of ligand | 2.13e-08 | 40 | 159 | 7 | GO:1901099 | |
| GeneOntologyBiologicalProcess | negative regulation of extrinsic apoptotic signaling pathway in absence of ligand | 2.13e-08 | 40 | 159 | 7 | GO:2001240 | |
| GeneOntologyBiologicalProcess | regulation of extrinsic apoptotic signaling pathway in absence of ligand | 1.85e-07 | 54 | 159 | 7 | GO:2001239 | |
| GeneOntologyBiologicalProcess | extrinsic apoptotic signaling pathway in absence of ligand | 2.30e-07 | 82 | 159 | 8 | GO:0097192 | |
| GeneOntologyBiologicalProcess | signal transduction in absence of ligand | 2.77e-07 | 84 | 159 | 8 | GO:0038034 | |
| GeneOntologyBiologicalProcess | negative regulation of extrinsic apoptotic signaling pathway | 2.70e-06 | 113 | 159 | 8 | GO:2001237 | |
| GeneOntologyBiologicalProcess | eosinophil chemotaxis | 3.12e-06 | 30 | 159 | 5 | GO:0048245 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 5.76e-06 | 16 | 159 | 4 | GO:0070424 | |
| GeneOntologyBiologicalProcess | eosinophil migration | 5.94e-06 | 34 | 159 | 5 | GO:0072677 | |
| GeneOntologyBiologicalProcess | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 7.97e-05 | 30 | 159 | 4 | GO:0035872 | |
| GeneOntologyBiologicalProcess | regulation of extrinsic apoptotic signaling pathway | 8.27e-05 | 181 | 159 | 8 | GO:2001236 | |
| GeneOntologyBiologicalProcess | cellular response to tumor necrosis factor | 8.41e-05 | 233 | 159 | 9 | GO:0071356 | |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process | ERBB3 EYA4 BIRC2 BIRC3 CCND1 EYA1 EYA2 EYA3 ADNP NDUFAF4 MTOR SCG2 AIPL1 PRAP1 KDM2B NLE1 CCL2 HSPA1A CX3CL1 HSPA1B PCID2 | 1.71e-04 | 1133 | 159 | 21 | GO:0043066 |
| GeneOntologyBiologicalProcess | cardiac muscle thin filament assembly | 1.76e-04 | 3 | 159 | 2 | GO:0071691 | |
| GeneOntologyBiologicalProcess | post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery | 1.76e-04 | 3 | 159 | 2 | GO:0000973 | |
| GeneOntologyBiologicalProcess | organelle assembly | SPAG1 SNX4 NRAP IFT172 SPEF2 CEP192 POGZ NEB CSMD2 PIK3C3 MTOR CFAP221 ANKRD1 NLE1 TNKS DIAPH3 HPS5 HSPA1A HSPA1B DNAH8 VPS13B | 1.81e-04 | 1138 | 159 | 21 | GO:0070925 |
| GeneOntologyBiologicalProcess | response to tumor necrosis factor | 1.82e-04 | 258 | 159 | 9 | GO:0034612 | |
| GeneOntologyBiologicalProcess | extrinsic apoptotic signaling pathway | 1.87e-04 | 259 | 159 | 9 | GO:0097191 | |
| GeneOntologyBiologicalProcess | positive regulation of Wnt signaling pathway | 2.28e-04 | 158 | 159 | 7 | GO:0030177 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation | FLT1 NOX5 IFT172 CCND1 EYA1 CASK MTOR RPTOR SCG2 CCL2 CCL13 SDR16C5 IQGAP3 TBX2 | 2.46e-04 | 603 | 159 | 14 | GO:0050673 |
| GeneOntologyBiologicalProcess | negative regulation of programmed cell death | ERBB3 EYA4 BIRC2 BIRC3 CCND1 EYA1 EYA2 EYA3 ADNP NDUFAF4 MTOR SCG2 AIPL1 PRAP1 KDM2B NLE1 CCL2 HSPA1A CX3CL1 HSPA1B PCID2 | 2.67e-04 | 1171 | 159 | 21 | GO:0043069 |
| GeneOntologyBiologicalProcess | positive regulation of pentose-phosphate shunt | 3.51e-04 | 4 | 159 | 2 | GO:1905857 | |
| GeneOntologyBiologicalProcess | response to heat | 3.54e-04 | 121 | 159 | 6 | GO:0009408 | |
| GeneOntologyBiologicalProcess | positive regulation of canonical Wnt signaling pathway | 3.54e-04 | 121 | 159 | 6 | GO:0090263 | |
| GeneOntologyBiologicalProcess | fatty acid beta-oxidation | 3.86e-04 | 80 | 159 | 5 | GO:0006635 | |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic signaling pathway | 3.88e-04 | 286 | 159 | 9 | GO:2001234 | |
| GeneOntologyBiologicalProcess | embryonic camera-type eye development | 3.96e-04 | 45 | 159 | 4 | GO:0031076 | |
| Domain | EYA_dom | 4.68e-09 | 4 | 156 | 4 | IPR006545 | |
| Domain | EYA_fam | 4.68e-09 | 4 | 156 | 4 | IPR028472 | |
| Domain | CX3CL1 | 2.27e-06 | 4 | 156 | 3 | IPR008097 | |
| Domain | SCY | 2.53e-05 | 42 | 156 | 5 | SM00199 | |
| Domain | Chemokine_IL8-like_dom | 3.18e-05 | 44 | 156 | 5 | IPR001811 | |
| Domain | IL8 | 3.18e-05 | 44 | 156 | 5 | PF00048 | |
| Domain | SMALL_CYTOKINES_CC | 6.07e-05 | 26 | 156 | 4 | PS00472 | |
| Domain | Chemokine_CC_CS | 6.07e-05 | 26 | 156 | 4 | IPR000827 | |
| Domain | A-amylase_C | 2.07e-04 | 3 | 156 | 2 | IPR031319 | |
| Domain | Nebulin | 4.11e-04 | 4 | 156 | 2 | PF00880 | |
| Domain | Alpha_amylase | 4.11e-04 | 4 | 156 | 2 | IPR006046 | |
| Domain | YEATS | 4.11e-04 | 4 | 156 | 2 | PS51037 | |
| Domain | NEBULIN | 4.11e-04 | 4 | 156 | 2 | PS51216 | |
| Domain | NEBU | 4.11e-04 | 4 | 156 | 2 | SM00227 | |
| Domain | Nebulin | 4.11e-04 | 4 | 156 | 2 | IPR013998 | |
| Domain | Aamy_C | 4.11e-04 | 4 | 156 | 2 | SM00632 | |
| Domain | YEATS | 4.11e-04 | 4 | 156 | 2 | IPR005033 | |
| Domain | Nebulin_repeat | 4.11e-04 | 4 | 156 | 2 | IPR000900 | |
| Domain | YEATS | 4.11e-04 | 4 | 156 | 2 | PF03366 | |
| Domain | ARM-type_fold | USP34 IFT172 TOGARAM2 RYR3 PIK3C3 MTOR RPTOR MROH2B DIAPH3 ARMC8 | 5.74e-04 | 339 | 156 | 10 | IPR016024 |
| Domain | Alpha-amylase_C | 6.82e-04 | 5 | 156 | 2 | PF02806 | |
| Domain | A-amylase/branching_C | 6.82e-04 | 5 | 156 | 2 | IPR006048 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 2.87e-05 | 23 | 111 | 4 | MM14953 | |
| Pathway | REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES | 8.36e-05 | 57 | 111 | 5 | M625 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HSV_GD_TO_HVEM_NFKB_SIGNALING_PATHWAY | 9.93e-05 | 12 | 111 | 3 | M47600 | |
| Pathway | KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY | 1.25e-04 | 62 | 111 | 5 | M15569 | |
| Pubmed | EYA4, a novel vertebrate gene related to Drosophila eyes absent. | 6.42e-09 | 6 | 160 | 4 | 9887327 | |
| Pubmed | TET2 USP34 EPRS1 DMXL2 ERBB3 TTC28 MYCBP2 IFT172 ABCC5 BIRC2 POGZ EYA3 CPNE5 RYR3 FAN1 CASK COG1 SCG2 MLLT3 TNKS HSPA1A HSPA1B ARMC8 | 2.70e-08 | 1285 | 160 | 23 | 35914814 | |
| Pubmed | TET2 USP34 NUP107 TTC28 MYCBP2 POGZ ADNP YEATS2 N4BP2 KDM2B DIAPH3 HSPA1A HSPA1B | 8.06e-08 | 418 | 160 | 13 | 34709266 | |
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 9020840 | ||
| Pubmed | Loss of cIAP1 attenuates soleus muscle pathology and improves diaphragm function in mdx mice. | 9.56e-08 | 3 | 160 | 3 | 23184147 | |
| Pubmed | Eyes absent represents a class of protein tyrosine phosphatases. | 9.56e-08 | 3 | 160 | 3 | 14628052 | |
| Pubmed | Misexpression of the eyes absent family triggers the apoptotic program. | 3.81e-07 | 4 | 160 | 3 | 11700312 | |
| Pubmed | 3.81e-07 | 4 | 160 | 3 | 21327296 | ||
| Pubmed | TET2 catalyzes active DNA demethylation of the Sry promoter and enhances its expression. | 5.66e-07 | 15 | 160 | 4 | 31530896 | |
| Pubmed | 9.49e-07 | 5 | 160 | 3 | 18660381 | ||
| Pubmed | 9.49e-07 | 5 | 160 | 3 | 9006082 | ||
| Pubmed | 9.49e-07 | 5 | 160 | 3 | 11735217 | ||
| Pubmed | 9.49e-07 | 5 | 160 | 3 | 28951461 | ||
| Pubmed | Cooperation of six and eya in activation of their target genes through nuclear translocation of Eya. | 9.49e-07 | 5 | 160 | 3 | 10490620 | |
| Pubmed | 9.49e-07 | 5 | 160 | 3 | 9195991 | ||
| Pubmed | Large-scale genotyping identifies 41 new loci associated with breast cancer risk. | 1.45e-06 | 76 | 160 | 6 | 23535729 | |
| Pubmed | CCR11 is a functional receptor for the monocyte chemoattractant protein family of chemokines. | 1.89e-06 | 6 | 160 | 3 | 10734104 | |
| Pubmed | 1.89e-06 | 6 | 160 | 3 | 8996246 | ||
| Pubmed | Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways. | 1.89e-06 | 6 | 160 | 3 | 10072545 | |
| Pubmed | 1.89e-06 | 6 | 160 | 3 | 27181207 | ||
| Pubmed | 2.82e-06 | 48 | 160 | 5 | 12080938 | ||
| Pubmed | 2.96e-06 | 22 | 160 | 4 | 9177770 | ||
| Pubmed | 3.30e-06 | 7 | 160 | 3 | 33150381 | ||
| Pubmed | 3.30e-06 | 7 | 160 | 3 | 25495686 | ||
| Pubmed | P-Rex1 links mammalian target of rapamycin signaling to Rac activation and cell migration. | 3.30e-06 | 7 | 160 | 3 | 17565979 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | USP34 NUP107 TTC28 ARHGAP17 CEP192 EYA3 DDX1 YEATS2 N4BP2 RPTOR MCM3AP KDM2B DIAPH3 | 3.68e-06 | 588 | 160 | 13 | 38580884 |
| Pubmed | GTPBP4 DMXL2 NUP107 MYCBP2 FAM98A CEP192 CASK FAM204A ESYT2 NDUFAF4 THEM4 N4BP2 TOMM34 SDF2L1 NLE1 DNAJC1 DIAPH3 PARD3 HSPA1A HSPA1B VPS13B | 5.09e-06 | 1487 | 160 | 21 | 33957083 | |
| Pubmed | DNA methyltransferase 3b regulates articular cartilage homeostasis by altering metabolism. | 5.26e-06 | 8 | 160 | 3 | 28614801 | |
| Pubmed | CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist. | 5.26e-06 | 8 | 160 | 3 | 10477718 | |
| Pubmed | Hsp72 preserves muscle function and slows progression of severe muscular dystrophy. | 5.26e-06 | 8 | 160 | 3 | 22495301 | |
| Pubmed | 5.26e-06 | 8 | 160 | 3 | 19865101 | ||
| Pubmed | 6.97e-06 | 27 | 160 | 4 | 12126650 | ||
| Pubmed | Dachshund homologues play a conserved role in islet cell development. | 6.97e-06 | 27 | 160 | 4 | 20869363 | |
| Pubmed | TET1 regulates fibroblast growth factor 8 transcription in gonadotropin releasing hormone neurons. | 7.87e-06 | 9 | 160 | 3 | 31361780 | |
| Pubmed | Beta cell replication is the primary mechanism for maintaining postnatal beta cell mass. | 7.87e-06 | 9 | 160 | 3 | 15467835 | |
| Pubmed | 8.10e-06 | 28 | 160 | 4 | 38492217 | ||
| Pubmed | GTPBP4 CACNA1E DMXL2 CTTNBP2 MYCBP2 ADNP TMEM132B CASK MTOR N4BP2 RPTOR PEX5 TNKS PARD3 HOMER2 ARMC8 | 1.04e-05 | 963 | 160 | 16 | 28671696 | |
| Pubmed | 1.07e-05 | 162 | 160 | 7 | 23012479 | ||
| Pubmed | Dysregulation of the TET family of epigenetic regulators in lymphoid and myeloid malignancies. | 1.12e-05 | 10 | 160 | 3 | 31467060 | |
| Pubmed | GTPBP4 NUP107 GART FAM98A HNRNPH1 ZNF12 EEF1D COG1 TTLL6 PRAP1 KDM2B DMD HSPA1A PCID2 | 1.12e-05 | 754 | 160 | 14 | 35906200 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TET2 TTC28 KLHDC2 MYCBP2 ARHGAP17 FAM98A CEP192 DDX1 ESYT2 PIK3C3 MTOR N4BP2 RPTOR PARD3 EIF4E2 | 1.15e-05 | 861 | 160 | 15 | 36931259 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | USP34 EYA4 IFT172 QTRT2 EYA1 EYA2 EYA3 CASK ESYT2 MTOR TOMM34 SDF2L1 TNKS DIAPH3 DMD ARMC8 | 1.20e-05 | 974 | 160 | 16 | 28675297 |
| Pubmed | Identification of Redox and Glucose-Dependent Txnip Protein Interactions. | 1.40e-05 | 32 | 160 | 4 | 27437069 | |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 1.42e-05 | 235 | 160 | 8 | 30258100 | |
| Pubmed | 1.59e-05 | 33 | 160 | 4 | 36522157 | ||
| Pubmed | A genome-wide scan of Ashkenazi Jewish Crohn's disease suggests novel susceptibility loci. | 1.60e-05 | 68 | 160 | 5 | 22412388 | |
| Pubmed | 2.04e-05 | 12 | 160 | 3 | 23569248 | ||
| Pubmed | Respiratory distress and early neonatal lethality in Hspa4l/Hspa4 double-mutant mice. | 2.04e-05 | 12 | 160 | 3 | 23980576 | |
| Pubmed | 2.04e-05 | 12 | 160 | 3 | 12149192 | ||
| Pubmed | TTC28 STXBP5 IFT172 CEP192 POGZ YEATS2 MCM3AP TET3 VPS13B PDZD2 | 2.07e-05 | 407 | 160 | 10 | 12693553 | |
| Pubmed | Exercise induces hepatosplanchnic release of heat shock protein 72 in humans. | 2.10e-05 | 2 | 160 | 2 | 12411538 | |
| Pubmed | The action of human pancreatic and salivary isoamylases on starch and glycogen. | 2.10e-05 | 2 | 160 | 2 | 890964 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 3786141 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 11922612 | ||
| Pubmed | Double somatic mosaic mutations in TET2 and DNMT3A--origin of peripheral T cell lymphoma in a case. | 2.10e-05 | 2 | 160 | 2 | 25687841 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 25046208 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 11376382 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 35931086 | ||
| Pubmed | Characterization of the binding between a 70-kDa heat shock protein, HspA1A, and phosphoinositides. | 2.10e-05 | 2 | 160 | 2 | 26923070 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 34654019 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 29728415 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 26976620 | ||
| Pubmed | Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma. | 2.10e-05 | 2 | 160 | 2 | 27852070 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 20235222 | ||
| Pubmed | Genetic determinants of HSP70 gene expression following heat shock. | 2.10e-05 | 2 | 160 | 2 | 20876613 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 20223214 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 20093776 | ||
| Pubmed | Bacterial infection elicits heat shock protein 72 release from pleural mesothelial cells. | 2.10e-05 | 2 | 160 | 2 | 23704948 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 35339897 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 17513788 | ||
| Pubmed | Ubiquitin-Mediated Regulation of RIPK1 Kinase Activity Independent of IKK and MK2. | 2.10e-05 | 2 | 160 | 2 | 29452637 | |
| Pubmed | IL-6 activates HSP72 gene expression in human skeletal muscle. | 2.10e-05 | 2 | 160 | 2 | 12207910 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 34039392 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 29572464 | ||
| Pubmed | Genomic characterization of the mouse inhibitor of apoptosis protein 1 and 2 genes. | 2.10e-05 | 2 | 160 | 2 | 9441758 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 28655780 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 32367481 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 12714332 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 19299581 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 9078371 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 21061259 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 33791790 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 16971451 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 31003094 | ||
| Pubmed | IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer. | 2.10e-05 | 2 | 160 | 2 | 20651737 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 29631603 | ||
| Pubmed | The human amylase-encoding genes amy2 and amy3 are identical to AMY2A and AMY2B. | 2.10e-05 | 2 | 160 | 2 | 2483397 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 10797013 | ||
| Pubmed | Role of membrane Hsp70 in radiation sensitivity of tumor cells. | 2.10e-05 | 2 | 160 | 2 | 26197988 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 24360193 | ||
| Pubmed | Activation of mTORC1 is essential for β-adrenergic stimulation of adipose browning. | 2.10e-05 | 2 | 160 | 2 | 27018708 | |
| Pubmed | Human pancreatic alpha-amylase: phenotypic codominance and new electrophoretic variants. | 2.10e-05 | 2 | 160 | 2 | 309725 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 19157555 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 11415446 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 37298493 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 36685592 | ||
| Pubmed | Proteinase-activated receptor-1, CCL2, and CCL7 regulate acute neutrophilic lung inflammation. | 2.10e-05 | 2 | 160 | 2 | 23972264 | |
| Pubmed | The actions of exogenous leucine on mTOR signalling and amino acid transporters in human myotubes. | 2.10e-05 | 2 | 160 | 2 | 21702994 | |
| Pubmed | Cathepsin S Contributes to the Pathogenesis of Muscular Dystrophy in Mice. | 2.10e-05 | 2 | 160 | 2 | 26966179 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 15498567 | ||
| Cytoband | 8q22.2 | 6.99e-05 | 23 | 160 | 3 | 8q22.2 | |
| Cytoband | 17q11.2-q12 | 2.51e-04 | 7 | 160 | 2 | 17q11.2-q12 | |
| GeneFamily | EYA transcriptional coactivator and phosphatases | 1.25e-09 | 4 | 109 | 4 | 1044 | |
| GeneFamily | Chemokine ligands|Endogenous ligands | 7.32e-06 | 45 | 109 | 5 | 483 | |
| GeneFamily | MTOR complex 1|MTOR complex 2 | 2.14e-04 | 4 | 109 | 2 | 1332 | |
| GeneFamily | Super elongation complex|YEATS domain containing | 2.14e-04 | 4 | 109 | 2 | 1283 | |
| GeneFamily | EF-hand domain containing|Nucleotide excision repair|Transcription and export complex 2 | 3.56e-04 | 5 | 109 | 2 | 1276 | |
| GeneFamily | Ring finger proteins|Baculoviral IAP repeat containing|Caspase recruitment domain containing | 9.85e-04 | 8 | 109 | 2 | 419 | |
| GeneFamily | Zinc fingers CXXC-type | 2.28e-03 | 12 | 109 | 2 | 136 | |
| GeneFamily | Dyneins, axonemal | 4.62e-03 | 17 | 109 | 2 | 536 | |
| GeneFamily | Heat shock 70kDa proteins | 4.62e-03 | 17 | 109 | 2 | 583 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 4.62e-03 | 17 | 109 | 2 | 684 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#2_top-relative-expression-ranked_200 | 1.06e-05 | 67 | 158 | 6 | gudmap_developingKidney_e15.5_Cap mesenchyme_200_k2 | |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_top-relative-expression-ranked_1000 | FLT1 TTC28 FAM13C BIRC3 IRF1 LRRK1 PARP14 PREX2 BCLAF3 IRF9 ESYT2 GVINP1 DMD HERC6 HSPA1A HSPA1B DCBLD2 CTSS FRMD3 | 2.72e-05 | 872 | 158 | 19 | gudmap_kidney_adult_Mesangium_Meis_1000 |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.46e-07 | 164 | 160 | 8 | d9531848105d606adedde65426177cf851140e31 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.46e-07 | 164 | 160 | 8 | e4d4c59aebe5cacd4ecdb907facd044dc82a831d | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.98e-07 | 180 | 160 | 8 | c72f15763ba707189e29c85db533557f01c7fdb1 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.25e-07 | 182 | 160 | 8 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 4.87e-07 | 192 | 160 | 8 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 5.70e-07 | 196 | 160 | 8 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | AT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 5.92e-07 | 197 | 160 | 8 | 5e0d222872a25bb9e9069d3dffda2844bb69874a | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 6.39e-07 | 199 | 160 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 6.63e-07 | 200 | 160 | 8 | d5426cd318a8f90c0bd8f9804351ab230fafc995 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.63e-07 | 200 | 160 | 8 | 21d9cf3cd3696ad6b745c7c036798f04b6ce5160 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.63e-07 | 200 | 160 | 8 | 33658d5d09e2eaff60f4dd88837d4252328eab63 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 1.27e-06 | 151 | 160 | 7 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.44e-06 | 154 | 160 | 7 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.44e-06 | 154 | 160 | 7 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.51e-06 | 155 | 160 | 7 | 8e239470799426ea474a36f57e1b7e0d9365ca5f | |
| ToppCell | Control-Epithelial_airway|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.71e-06 | 158 | 160 | 7 | 35aee1c3b92169e73569331022833cb44ab7e7e8 | |
| ToppCell | Ciliated_cells-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.20e-06 | 164 | 160 | 7 | 0e9961acbb1d6c0089e6805ba6756736fa4d8bed | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-06 | 178 | 160 | 7 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.92e-06 | 179 | 160 | 7 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | facs-GAT-Fat-3m-Epithelial|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.22e-06 | 181 | 160 | 7 | 11cb84528f7ca084f0a92eda4f2e18e63a428fe9 | |
| ToppCell | facs-GAT-Fat-3m-Epithelial-epithelial_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.22e-06 | 181 | 160 | 7 | e97cbaafb93fdbee8e3cf4a06e6bcf121d941403 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.22e-06 | 181 | 160 | 7 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | facs-GAT-Fat-3m-Epithelial-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.22e-06 | 181 | 160 | 7 | 5ffeca29e4d31a20c110d27af128ed024a79ad56 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 4.37e-06 | 182 | 160 | 7 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.37e-06 | 182 | 160 | 7 | 215c303df42f13597b2c7a95cb157c6bc7aca9a1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.53e-06 | 183 | 160 | 7 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 4.87e-06 | 185 | 160 | 7 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.87e-06 | 185 | 160 | 7 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | normal_Lung-Myeloid_cells-Activated_DCs|normal_Lung / Location, Cell class and cell subclass | 5.04e-06 | 186 | 160 | 7 | 0987c9a39503eb6c75a2bf4db98b2b2fd46956fb | |
| ToppCell | normal_Lung-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 5.04e-06 | 186 | 160 | 7 | 00ad1239b952119b3fd2e6af8f034cba3488f9c1 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.23e-06 | 187 | 160 | 7 | 218c9b4f28499389c43005d9626af2ac01066027 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.23e-06 | 187 | 160 | 7 | c7ac4b328efc2ebb72f71154661914193ff402ca | |
| ToppCell | Control-Myeloid-DC_Mature|Control / Disease state, Lineage and Cell class | 5.23e-06 | 187 | 160 | 7 | 049780ca2a3e6adcd89dc2cf3095b5ad068b244a | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 5.41e-06 | 188 | 160 | 7 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 5.41e-06 | 188 | 160 | 7 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 5.41e-06 | 188 | 160 | 7 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.41e-06 | 188 | 160 | 7 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.60e-06 | 189 | 160 | 7 | b55de812043b670cbde810d7d42f45909b6d66ef | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.60e-06 | 189 | 160 | 7 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.60e-06 | 189 | 160 | 7 | dc440015949a768188c67661b6be63b1ead1a0f0 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.60e-06 | 189 | 160 | 7 | 38cde34295566a4ecaf7d0a81c5a192cf17d0459 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.60e-06 | 189 | 160 | 7 | b4b93bd10b7e3cc16e54ff73beac230f519c010a | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 5.60e-06 | 189 | 160 | 7 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.60e-06 | 189 | 160 | 7 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 5.60e-06 | 189 | 160 | 7 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.60e-06 | 189 | 160 | 7 | 4e83e49d1265ffe507fdb72924c77c4d1c73f0bd | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 5.80e-06 | 190 | 160 | 7 | 651a1d3ae286e40f9d9f60e438211c6148d24143 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.00e-06 | 191 | 160 | 7 | 96483adb97c81208aa513782550acd8a08b63866 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.00e-06 | 191 | 160 | 7 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.00e-06 | 191 | 160 | 7 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.00e-06 | 191 | 160 | 7 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 6.21e-06 | 192 | 160 | 7 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 | |
| ToppCell | ASK440-Epithelial-Ciliated|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.43e-06 | 193 | 160 | 7 | a0baa8be6f590b2031fede22be588715ae458e93 | |
| ToppCell | ASK440-Epithelial-Secretory|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.43e-06 | 193 | 160 | 7 | 50e98d91697c7af6a3de39e52edde6dd2b67b512 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-myofibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.43e-06 | 193 | 160 | 7 | 02dfd1df1e7fc84bfca2b0c95138b5b4408bb5d1 | |
| ToppCell | ASK440-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.65e-06 | 194 | 160 | 7 | c84a7fa94fb06e08aae04db56c8c313b0afde1d7 | |
| ToppCell | 368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 6.65e-06 | 194 | 160 | 7 | 58046894446cb250814252a23f60fdd59c114d77 | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 6.65e-06 | 194 | 160 | 7 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | BL-critical-LOC-Epithelial-unknown_epithelial|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.65e-06 | 194 | 160 | 7 | 6140ff8e776429c9593607da418b2d9c4f399d41 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 6.87e-06 | 195 | 160 | 7 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.87e-06 | 195 | 160 | 7 | d211a836cf711fdb91b10d512f09d462be937cc5 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 6.87e-06 | 195 | 160 | 7 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | BL-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.87e-06 | 195 | 160 | 7 | 07a6bcef6af93ed87df455dee624037cb75e011a | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 6.87e-06 | 195 | 160 | 7 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 7.11e-06 | 196 | 160 | 7 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 7.11e-06 | 196 | 160 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 7.11e-06 | 196 | 160 | 7 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.35e-06 | 197 | 160 | 7 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.35e-06 | 197 | 160 | 7 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.35e-06 | 197 | 160 | 7 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.35e-06 | 197 | 160 | 7 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.35e-06 | 197 | 160 | 7 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | LPS_only-Epithelial_airway|LPS_only / Treatment groups by lineage, cell group, cell type | 7.59e-06 | 198 | 160 | 7 | ba090210392e001a3f7bdf09371b3f0e0c8c7ef3 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.59e-06 | 198 | 160 | 7 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial|LPS_only / Treatment groups by lineage, cell group, cell type | 7.59e-06 | 198 | 160 | 7 | e035380578c01b0243bfef29ca9b50cc17cce771 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.11e-06 | 200 | 160 | 7 | 926a7ea94b5908aebf103893ea83ce9d25285b65 | |
| ToppCell | Biopsy_IPF-Epithelial-Ciliated|Biopsy_IPF / Sample group, Lineage and Cell type | 8.11e-06 | 200 | 160 | 7 | bb8c99156e547a8eb6599b6b6bc3c66bf77af7f8 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.11e-06 | 200 | 160 | 7 | f1a49bc818054fb0734d3b84725ee6487b034567 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.11e-06 | 200 | 160 | 7 | 06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.11e-06 | 200 | 160 | 7 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb | |
| ToppCell | Biopsy_Other_PF-Epithelial-Ciliated|Biopsy_Other_PF / Sample group, Lineage and Cell type | 8.11e-06 | 200 | 160 | 7 | 721371698bce8890853fb6b6b01a2c20293b39e9 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.11e-06 | 200 | 160 | 7 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Ciliated|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 8.11e-06 | 200 | 160 | 7 | d7ae09189cf0b7e2f7e7fc6b0921975b75aa7d62 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.11e-06 | 200 | 160 | 7 | cf59110547cc66b5f4a2999735336b0309ba9b0d | |
| ToppCell | Globus_pallidus-Macroglia-CSF_related-EPENDYMAL-Ependymal_(Ccdc153)--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.70e-06 | 133 | 160 | 6 | a653282bf871dc9eb47fbf1d55b1eb32ae749c04 | |
| ToppCell | Globus_pallidus-Macroglia-CSF_related-EPENDYMAL-Ependymal_(Ccdc153)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.70e-06 | 133 | 160 | 6 | 2caaacb4fb4358c5589c81eaf8dffb85f318fb13 | |
| ToppCell | Globus_pallidus-Macroglia-CSF_related-EPENDYMAL|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.70e-06 | 133 | 160 | 6 | 2d0cade52d79c3d0b6f77418103244150e2ea7fb | |
| ToppCell | Globus_pallidus-Macroglia-CSF_related-EPENDYMAL-Ependymal_(Ccdc153)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.70e-06 | 133 | 160 | 6 | 25ea1d82a0fc9fed191b9dd33f2a35404a665e7d | |
| ToppCell | Globus_pallidus-Macroglia-CSF_related|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.70e-06 | 133 | 160 | 6 | 51c60b6d5648968783bffbb22c28d9abaf6243d5 | |
| ToppCell | (08)_PNEC-(2)_48hpi|(08)_PNEC / shred by cell type and Timepoint | 1.26e-05 | 142 | 160 | 6 | e95d34170f5053678e0dd9793e68d93c03b05822 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.60e-05 | 148 | 160 | 6 | d61123f0c811287843d066b932b4a9ff09c07c5b | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.60e-05 | 148 | 160 | 6 | c8e93b87212f55774223caa385859c566fa1981f | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-05 | 157 | 160 | 6 | 9021900d9b1a71210c9c414a9d165eaf399eb607 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-05 | 157 | 160 | 6 | c8c627ca181856cd31dba4cf073c2be659a49dc1 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-05 | 162 | 160 | 6 | 93bd29c52846c3156b8b0d2e39c552373efdfe93 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Mes-Epi-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.85e-05 | 164 | 160 | 6 | 4307b002fb41ddfc7ab8a6bca66a60942c250052 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Mes-Epi-like-Airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.85e-05 | 164 | 160 | 6 | 1d84aa5b925f502ee9c5fa39714490f613a58028 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)-DC2_L.1.2.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.95e-05 | 165 | 160 | 6 | 76abebe80e5f8bf44825bb619ae86fcb6f66ffeb | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-Enterocyte_(Proximal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 166 | 160 | 6 | 22b31acbbef1936ce19b393cf880c63ea2fa0f1b | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-05 | 168 | 160 | 6 | d69452e2cfeb74023b5cf3d09064d7dcad0008ec | |
| Drug | AC1NUKN7 | 1.33e-06 | 4 | 159 | 3 | CID005481434 | |
| Disease | eye disease (implicated_via_orthology) | 1.03e-08 | 6 | 153 | 4 | DOID:5614 (implicated_via_orthology) | |
| Disease | branchiootorenal syndrome (implicated_via_orthology) | 2.40e-08 | 7 | 153 | 4 | DOID:14702 (implicated_via_orthology) | |
| Disease | leukemia | 9.91e-06 | 55 | 153 | 5 | C0023418 | |
| Disease | cardiovascular system disease (is_marker_for) | 1.60e-05 | 10 | 153 | 3 | DOID:1287 (is_marker_for) | |
| Disease | pulmonary embolism (biomarker_via_orthology) | 2.91e-05 | 12 | 153 | 3 | DOID:9477 (biomarker_via_orthology) | |
| Disease | hepatocellular carcinoma (is_marker_for) | 2.93e-05 | 301 | 153 | 9 | DOID:684 (is_marker_for) | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 7.29e-05 | 16 | 153 | 3 | C0334634 | |
| Disease | Glycodeoxycholate sulfate measurement | 7.99e-05 | 3 | 153 | 2 | EFO_0022098 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.20e-04 | 447 | 153 | 10 | EFO_0000694, MONDO_0100096 | |
| Disease | acute myeloid leukemia (is_marker_for) | 1.23e-04 | 49 | 153 | 4 | DOID:9119 (is_marker_for) | |
| Disease | end stage renal disease (implicated_via_orthology) | 1.46e-04 | 20 | 153 | 3 | DOID:783 (implicated_via_orthology) | |
| Disease | chronic obstructive pulmonary disease (is_marker_for) | 1.54e-04 | 97 | 153 | 5 | DOID:3083 (is_marker_for) | |
| Disease | Glycochenodeoxycholate sulfate measurement | 1.59e-04 | 4 | 153 | 2 | EFO_0022097 | |
| Disease | Angioimmunoblastic Lymphadenopathy | 1.59e-04 | 4 | 153 | 2 | C0020981 | |
| Disease | glycodeoxycholate 3-sulfate measurement | 1.59e-04 | 4 | 153 | 2 | EFO_0800385 | |
| Disease | status epilepticus (implicated_via_orthology) | 1.70e-04 | 21 | 153 | 3 | DOID:1824 (implicated_via_orthology) | |
| Disease | Nephritis, Interstitial | 2.55e-04 | 24 | 153 | 3 | C0027707 | |
| Disease | graft-versus-host disease (biomarker_via_orthology) | 2.64e-04 | 5 | 153 | 2 | DOID:0081267 (biomarker_via_orthology) | |
| Disease | Duchenne and Becker Muscular Dystrophy | 2.64e-04 | 5 | 153 | 2 | C3542021 | |
| Disease | Becker Muscular Dystrophy | 2.64e-04 | 5 | 153 | 2 | C0917713 | |
| Disease | Major Depressive Disorder | 2.88e-04 | 243 | 153 | 7 | C1269683 | |
| Disease | Left Ventricular Hypertrophy | 2.89e-04 | 25 | 153 | 3 | C0149721 | |
| Disease | Myocardial Ischemia | 3.23e-04 | 176 | 153 | 6 | C0151744 | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 3.26e-04 | 63 | 153 | 4 | DOID:0050866 (is_marker_for) | |
| Disease | Allergic Reaction | 3.26e-04 | 63 | 153 | 4 | C1527304 | |
| Disease | Hypersensitivity | 3.47e-04 | 64 | 153 | 4 | C0020517 | |
| Disease | age related macular degeneration (implicated_via_orthology) | 3.95e-04 | 6 | 153 | 2 | DOID:10871 (implicated_via_orthology) | |
| Disease | crescentic glomerulonephritis (implicated_via_orthology) | 3.95e-04 | 6 | 153 | 2 | DOID:13139 (implicated_via_orthology) | |
| Disease | Leukemia, Myelomonocytic, Chronic | 3.95e-04 | 6 | 153 | 2 | C0023480 | |
| Disease | Muscular Dystrophy, Duchenne | 3.95e-04 | 6 | 153 | 2 | C0013264 | |
| Disease | Unipolar Depression | 4.23e-04 | 259 | 153 | 7 | C0041696 | |
| Disease | C-C motif chemokine 7 measurement | 4.52e-04 | 29 | 153 | 3 | EFO_0008054 | |
| Disease | asthma (is_marker_for) | 5.18e-04 | 126 | 153 | 5 | DOID:2841 (is_marker_for) | |
| Disease | taurochenodeoxycholic acid 3-sulfate measurement | 5.51e-04 | 7 | 153 | 2 | EFO_0800584 | |
| Disease | colon adenoma (is_marker_for) | 5.51e-04 | 7 | 153 | 2 | DOID:0050912 (is_marker_for) | |
| Disease | Severe Congenital Microcephaly | 5.52e-04 | 31 | 153 | 3 | C3853041 | |
| Disease | renal cell carcinoma (is_marker_for) | 5.56e-04 | 128 | 153 | 5 | DOID:4450 (is_marker_for) | |
| Disease | lysophosphatidylcholine 20:4 measurement | 6.07e-04 | 32 | 153 | 3 | EFO_0010363 | |
| Disease | cortical surface area measurement | TET2 USP34 ERBB3 CTTNBP2 MYCBP2 TUT7 EYA1 HNRNPH1 FBXO16 NTN4 MLLT3 EEF1AKMT2 TNKS DIAPH3 PARD3 SDR16C5 PDZD2 | 6.35e-04 | 1345 | 153 | 17 | EFO_0010736 |
| Disease | Microlissencephaly | 6.65e-04 | 33 | 153 | 3 | C1956147 | |
| Disease | familial hyperlipidemia (is_implicated_in) | 7.33e-04 | 8 | 153 | 2 | DOID:1168 (is_implicated_in) | |
| Disease | alcoholic hepatitis (is_marker_for) | 7.33e-04 | 8 | 153 | 2 | DOID:12351 (is_marker_for) | |
| Disease | Kartagener Syndrome | 7.92e-04 | 35 | 153 | 3 | C0022521 | |
| Disease | lung disease (biomarker_via_orthology) | 7.92e-04 | 35 | 153 | 3 | DOID:850 (biomarker_via_orthology) | |
| Disease | Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus | 7.92e-04 | 35 | 153 | 3 | C4551906 | |
| Disease | posterior thigh muscle fat infiltration measurement | 7.92e-04 | 35 | 153 | 3 | EFO_0020934 | |
| Disease | Polynesian Bronchiectasis | 7.92e-04 | 35 | 153 | 3 | C4317124 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 8.08e-04 | 139 | 153 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 8.09e-04 | 80 | 153 | 4 | DOID:6432 (biomarker_via_orthology) | |
| Disease | breast carcinoma | TET2 NRAP TTC28 IRF1 ADAM29 CHST9 CCND1 CEP192 CPNE5 CCL28 DNAJC1 DMD DNMT3A COL1A1 | 8.82e-04 | 1019 | 153 | 14 | EFO_0000305 |
| Disease | tongue squamous cell carcinoma (is_marker_for) | 9.33e-04 | 37 | 153 | 3 | DOID:0050865 (is_marker_for) | |
| Disease | corneodesmosin measurement | 9.39e-04 | 9 | 153 | 2 | EFO_0801499 | |
| Disease | alpha-amylase 1 measurement | 9.39e-04 | 9 | 153 | 2 | EFO_0801371 | |
| Disease | Major depression, single episode | 9.39e-04 | 9 | 153 | 2 | C0024517 | |
| Disease | aggressive periodontitis (is_implicated_in) | 9.39e-04 | 9 | 153 | 2 | DOID:1474 (is_implicated_in) | |
| Disease | glycochenodeoxycholate 3-sulfate measurement | 9.39e-04 | 9 | 153 | 2 | EFO_0800384 | |
| Disease | Autism Spectrum Disorders | 1.02e-03 | 85 | 153 | 4 | C1510586 | |
| Disease | ductal carcinoma in situ (is_marker_for) | 1.09e-03 | 39 | 153 | 3 | DOID:0060074 (is_marker_for) | |
| Disease | Peripheral T-Cell Lymphoma | 1.17e-03 | 10 | 153 | 2 | C0079774 | |
| Disease | Eczema | 1.21e-03 | 310 | 153 | 7 | HP_0000964 | |
| Disease | Multiple Myeloma | 1.35e-03 | 42 | 153 | 3 | C0026764 | |
| Disease | Tumoral calcinosis | 1.35e-03 | 42 | 153 | 3 | C0263628 | |
| Disease | Calcinosis | 1.35e-03 | 42 | 153 | 3 | C0006663 | |
| Disease | Microcalcification | 1.35e-03 | 42 | 153 | 3 | C0521174 | |
| Disease | Macrocephaly | 1.42e-03 | 11 | 153 | 2 | C0221355 | |
| Disease | Lymphoma, Lymphocytic, Intermediate | 1.42e-03 | 11 | 153 | 2 | C0751958 | |
| Disease | Complications of Diabetes Mellitus | 1.42e-03 | 11 | 153 | 2 | C0342257 | |
| Disease | dilated cardiomyopathy (is_implicated_in) | 1.45e-03 | 43 | 153 | 3 | DOID:12930 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | FLT1 ERBB3 BIRC2 CCND1 GALNT16 HP MTOR N4BP2 NLE1 DHX32 DMD HSPA1B VPS13B DNMT3A | 1.45e-03 | 1074 | 153 | 14 | C0006142 |
| Disease | Thyroid carcinoma | 1.55e-03 | 44 | 153 | 3 | C0549473 | |
| Disease | ureteral obstruction (biomarker_via_orthology) | 1.65e-03 | 45 | 153 | 3 | DOID:5199 (biomarker_via_orthology) | |
| Disease | calcium measurement | 1.68e-03 | 628 | 153 | 10 | EFO_0004838 | |
| Disease | macular retinal edema (is_marker_for) | 1.70e-03 | 12 | 153 | 2 | DOID:4449 (is_marker_for) | |
| Disease | Mammary Carcinoma, Human | 1.74e-03 | 525 | 153 | 9 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 1.74e-03 | 525 | 153 | 9 | C1257931 | |
| Disease | Mammary Neoplasms | 1.78e-03 | 527 | 153 | 9 | C1458155 | |
| Disease | Primary Ciliary Dyskinesia | 1.88e-03 | 47 | 153 | 3 | C4551720 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 1.92e-03 | 169 | 153 | 5 | DOID:3908 (is_marker_for) | |
| Disease | COVID-19, mortality | 1.97e-03 | 170 | 153 | 5 | EFO_0004352, MONDO_0100096 | |
| Disease | intracranial aneurysm (biomarker_via_orthology) | 2.01e-03 | 13 | 153 | 2 | DOID:10941 (biomarker_via_orthology) | |
| Disease | Breast Carcinoma | 2.05e-03 | 538 | 153 | 9 | C0678222 | |
| Disease | HIV Infections | 2.06e-03 | 103 | 153 | 4 | C0019693 | |
| Disease | HIV Coinfection | 2.06e-03 | 103 | 153 | 4 | C4505456 | |
| Disease | Schizophrenia | ERBB3 CCND1 CSMD2 ADNP HP PIK3C3 MTOR KDM2B CCL2 HSPA1A HSPA1B HOMER2 | 2.25e-03 | 883 | 153 | 12 | C0036341 |
| Disease | Kawasaki disease (is_marker_for) | 2.33e-03 | 14 | 153 | 2 | DOID:13378 (is_marker_for) | |
| Disease | asthma, body mass index | 2.33e-03 | 14 | 153 | 2 | EFO_0004340, MONDO_0004979 | |
| Disease | vascular dementia (biomarker_via_orthology) | 2.33e-03 | 14 | 153 | 2 | DOID:8725 (biomarker_via_orthology) | |
| Disease | Kuhnt-Junius degeneration (is_marker_for) | 2.33e-03 | 14 | 153 | 2 | DOID:10873 (is_marker_for) | |
| Disease | unipolar depression, sex interaction measurement | 2.37e-03 | 51 | 153 | 3 | EFO_0003761, EFO_0008343 | |
| Disease | lymphocyte percentage of leukocytes | TET2 SPAG1 TTC28 STXBP5 IRF1 LRRK1 HNRNPH1 KDM2B CTSS DNMT3A | 2.54e-03 | 665 | 153 | 10 | EFO_0007993 |
| Disease | hepatocellular carcinoma (is_implicated_in) | 2.59e-03 | 181 | 153 | 5 | DOID:684 (is_implicated_in) | |
| Disease | systemic scleroderma (is_marker_for) | 2.65e-03 | 53 | 153 | 3 | DOID:418 (is_marker_for) | |
| Disease | non-alcoholic fatty liver disease | 2.65e-03 | 182 | 153 | 5 | EFO_0003095 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 2.68e-03 | 15 | 153 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 2.68e-03 | 15 | 153 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 2.68e-03 | 15 | 153 | 2 | C0154091 | |
| Disease | vitamin K-dependent protein C measurement | 2.68e-03 | 15 | 153 | 2 | EFO_0008318 | |
| Disease | Pneumonia | 2.79e-03 | 54 | 153 | 3 | C0032285 | |
| Disease | Lobar Pneumonia | 2.79e-03 | 54 | 153 | 3 | C0032300 | |
| Disease | Pneumonitis | 2.79e-03 | 54 | 153 | 3 | C3714636 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SAHKDMWLSVVKFLP | 81 | Q9BV23 | |
| EEERNPLKNIKWMTH | 56 | Q86UN6 | |
| PLKNIKWMTHGEFTV | 61 | Q86UN6 | |
| KWKSENITPRMQHDT | 271 | Q9UKF5 | |
| LNKVKHEMDFDAEWL | 831 | Q9H2P0 | |
| QDWLHPLMDKVVTFA | 541 | Q17RC7 | |
| AKTPIKWMALESIHF | 871 | P21860 | |
| TVKHMWPFICQFIEK | 201 | A0FGR8 | |
| PHNHTVKQWMKVQAA | 76 | Q9NRJ3 | |
| KNEQHTVMKLPWDSL | 446 | P41214 | |
| TWNLSNHEKMKAVPV | 166 | Q9NZN9 | |
| PVEIFMNKFKDDHWA | 3341 | Q7Z408 | |
| QKETLAIWPHLSQKM | 1836 | Q15878 | |
| QHFPVFMNEKEDILW | 846 | Q9Y6K1 | |
| KTPMDLVLHWQNGTK | 286 | Q15327 | |
| DPKEKWVQNYMKHLG | 76 | Q99616 | |
| KKPTVEGFTHDWMVF | 21 | P42568 | |
| EPHDNENNKWEMIKN | 841 | Q7Z2Y8 | |
| YWDLMNLSEKHDKIP | 416 | Q9BZE4 | |
| KLSNWEPKDNAMSEH | 211 | Q13489 | |
| NKLKWNLAAMTPHDF | 146 | P24385 | |
| EWNKNPDMLFTIHPV | 501 | Q8TDJ6 | |
| HIQTLKKWMAEVDVF | 1056 | P11532 | |
| LDASKHMWPGDIKAI | 211 | P19961 | |
| PHEMTENCFWIKVNE | 656 | Q9NSV4 | |
| MPEWVLFHKFSISEN | 661 | Q7L7V1 | |
| ASEKNERLLMKPQWH | 206 | Q96KC8 | |
| GIPIDMWNKFQELHK | 71 | Q9H8W3 | |
| MATNFLAHEKIWFDK | 1 | P29692 | |
| DKSMGQKWEHFITAP | 201 | Q8IWA6 | |
| HFKWEQIPLEQKMTR | 266 | Q8N428 | |
| LMEKSFDVNFKAHLW | 141 | Q8N3Y7 | |
| HCIDISDMKWQKLNP | 221 | Q7Z6M1 | |
| EEIAAKQHNMPFWRI | 541 | Q99504 | |
| WINKEEMIFQIPWKH | 26 | P10914 | |
| NEWFKHMNSVPQKPA | 761 | P57740 | |
| QDNMKLHKVDFIWIN | 626 | Q96PH1 | |
| KGSWVNKFPVEMTHN | 296 | P05546 | |
| LDASKHMWPGDIKAI | 211 | P04746 | |
| KMNPRQWSHISESAK | 236 | O14936 | |
| NNPIKKWAKDMNRHF | 1066 | O00370 | |
| HLDAKGSFPWQAKMV | 166 | P00738 | |
| HFTALPTDMKVEWAK | 901 | Q86VF7 | |
| HKFTALPEDLKMAWA | 1386 | Q86VF7 | |
| PDKMAVFWKNHLKDV | 441 | Q38SD2 | |
| AHVFQIDPNTKKNWM | 11 | Q9NSB8 | |
| KDMAIFWHRKKISPN | 496 | O60318 | |
| QEWLSHLEKTFAMKD | 641 | Q9UPZ3 | |
| KISEAEAVHPVKNWM | 211 | O95822 | |
| KIMHFPTWVDLKGED | 421 | Q92499 | |
| RKFGDPVVQSDMKHW | 76 | P0DMV9 | |
| DMKHWPFQVINDGDK | 86 | P0DMV9 | |
| RPIMAWFKEINKHNQ | 1796 | O15018 | |
| AVQQDPKHMEAWQYL | 361 | P50542 | |
| PEVGLDNKMKLFLHW | 251 | A6NFA0 | |
| KSWIKIMQRAHENPN | 1526 | Q96JB1 | |
| KMHIKSPTDFEWLKQ | 1771 | Q96JB1 | |
| EQGAKKHAMPFWRIS | 561 | Q99502 | |
| MHIIKAQPFKDRCEW | 516 | Q8IYU2 | |
| PECPVMHDSKNWKNL | 486 | Q8IVU3 | |
| MHDSKNWKNLVVPFA | 491 | Q8IVU3 | |
| SHLRGPFKEVQWNKM | 616 | Q9NVC6 | |
| FKSNNVEMDWVLKHT | 86 | P31943 | |
| KQRPADTAFWVQHDM | 661 | Q86VI3 | |
| PKEAVLMFVHNQDWE | 1171 | Q9UG01 | |
| SWAEPQLKAMKALQH | 46 | Q86XN7 | |
| WSMLPDVIDDFHLKQ | 416 | Q8NA29 | |
| SKVDIPAHWSDMKQQ | 1601 | Q460N5 | |
| PHIKIEMKNATLAWD | 486 | O15440 | |
| QAHKEENWALPVMYA | 96 | Q5JVF3 | |
| VSKFMAIQKALQPDW | 126 | Q9H974 | |
| WLEPNKSIFKQMKTH | 86 | A2A2Y4 | |
| DPDEIMWFKKLHLVN | 81 | Q15067 | |
| MWFKKLHLVNFVEPV | 86 | Q15067 | |
| SFQDHAVWKPLMKVL | 421 | Q8IUR7 | |
| EEEQAAKKHNMPFWR | 606 | O95677 | |
| NMWPQHLKEKQTEAT | 201 | Q8NHM5 | |
| PVAWRMDSEKHGQSK | 46 | A2AJT9 | |
| KVDFLWHPEVNGSMK | 131 | Q96PB1 | |
| LQEEMKLCSWFKHLP | 311 | Q8WTW3 | |
| AKKWNEEHLHTVNPM | 336 | Q8TD57 | |
| ADPKQKWVQDSMDHL | 76 | P13500 | |
| SPWDFMRKNKAEHIT | 1071 | Q8WZ74 | |
| TQMPKWKESSHQGAA | 806 | Q6ZTQ4 | |
| WMQKHKIPLDASVLD | 71 | Q5JPI9 | |
| QSALDRMKNPVTKHW | 811 | Q6ZN28 | |
| DSPIDFHLQSWMNNK | 156 | Q8TEP8 | |
| FHLQSWMNNKEPKIV | 161 | Q8TEP8 | |
| TMFRIPWKHAGKQDF | 36 | Q00978 | |
| KEMLANSWNCLPKHL | 376 | Q9Y2U9 | |
| HLSAKKLPNWQMEVS | 451 | Q13118 | |
| IWEKNLKFVMLHNLE | 51 | P25774 | |
| WKGMKQFLPAKAVDH | 576 | Q96PD2 | |
| RKFGDPVVQSDMKHW | 76 | P0DMV8 | |
| DMKHWPFQVINDGDK | 86 | P0DMV8 | |
| ADPTQKWVQDFMKHL | 76 | P80098 | |
| PFEQGIWKKHYIQMV | 146 | Q8IX29 | |
| SDFHLFKEGIKPMWE | 111 | O60573 | |
| PLSMIFKLQNAFWEH | 371 | Q8WUF5 | |
| HKTEVMKNTLNPVWQ | 216 | Q9HCH3 | |
| VPIKMQVKHWPSEQD | 26 | Q96NZ9 | |
| HPMVGKWLEKQEQDE | 226 | Q8TEW0 | |
| VSIGMFVNHKWPQKA | 176 | Q12908 | |
| KEMQKPQWYRHTFEE | 226 | P42345 | |
| LKWQVHLGKDPMSFK | 376 | Q4G0U5 | |
| EEQGAKKHNMPFWRI | 506 | O00167 | |
| VKMKWQFEHTKPTPF | 311 | P03891 | |
| VKGPNDRLSHKQMIW | 976 | Q9Y2M0 | |
| IKKSVNPQWNHTFMF | 631 | Q8TDW5 | |
| WDVKAQKLAMDLPGH | 441 | Q9NVX2 | |
| DTMTHNNFWLKKIEI | 46 | O95219 | |
| NNLIPYKLMHDWKEL | 451 | Q9C093 | |
| KDIEFMIGHKPNIFW | 516 | Q695T7 | |
| HRKNPIEKNLQMWEE | 311 | P07814 | |
| MDKFPFNWKLKSHIL | 111 | Q14DG7 | |
| KVNQWALESFAKMIP | 821 | Q6ZUX3 | |
| EEIFKKAGHPFMWNQ | 261 | P06732 | |
| IVNMKSFVQHWKPSL | 601 | Q9HB63 | |
| EMRAHQDKWAEKPAF | 236 | Q68EM7 | |
| MGPAHWEKIEAINQA | 196 | Q8NCA5 | |
| EWAFESEPLFLQHMK | 566 | Q7Z3K3 | |
| FRQGMHDLKVWPNVE | 136 | Q8NEB9 | |
| YETQQWPERKLKHMQ | 151 | P13521 | |
| LKSLTSHDPMKQWEV | 881 | Q92835 | |
| FSNGIKKAALMHKWP | 341 | O75592 | |
| HKLFPETWTAEKIMQ | 126 | Q9P032 | |
| LMHSKGDAKWIQSVP | 56 | Q06520 | |
| LWNLAHVKMEPQESE | 336 | O94864 | |
| SHGDKTSNPEVLKWM | 316 | Q8NE31 | |
| FSELMKEPILWKHGN | 1286 | Q7Z745 | |
| IMWNKAIELSSKSHP | 181 | Q5T5C0 | |
| WKNFADLEKNPEMVT | 1096 | Q8N122 | |
| KLSNWEPKDDAMSEH | 226 | Q13490 | |
| HPIFSFWDKKMQSRV | 56 | Q96M20 | |
| FSNMNWPVDIHPLNK | 146 | Q7L1S5 | |
| KNPKDKRHVWFGESM | 1316 | P02452 | |
| PDHAIQWDKSMCVKN | 306 | Q9UKZ1 | |
| KINAAWFKNMPHLKV | 301 | Q9NR97 | |
| WFKNMPHLKVLDLEF | 306 | Q9NR97 | |
| KRWNSLPSENHKEMA | 156 | Q15785 | |
| HLPSKMKVWQDDSIN | 121 | Q8TC36 | |
| SIQWSFFHKKEMEPI | 56 | Q86XK7 | |
| HWKFPQEQNKMKPEF | 436 | A6NCW7 | |
| THNTWKAMEGIFIKP | 196 | Q9HCN8 | |
| GEQWMAKPVAFHKLK | 196 | Q13207 | |
| WIQDFKTHFLDPKLM | 86 | Q5T1C6 | |
| KMPLKLLTNHYEQCW | 2501 | Q15413 | |
| TQWDPKKHVQEMPTD | 111 | O94759 | |
| MDLWQFTPLHEAASK | 431 | O95271 | |
| PLQAWHPAKEMISKQ | 591 | Q07617 | |
| NKWFVCMAKTPEEKH | 336 | Q70Z35 | |
| QPNHGLALWEAKMKQ | 1701 | O43151 | |
| NWTLLKSDMNKPHLI | 711 | Q8N841 | |
| KEFMDRHGIPTAQWK | 111 | P22102 | |
| LEQEKEPWNLKTHDM | 56 | Q6ZMV8 | |
| DEKVQAVHNLKMFWQ | 2351 | Q96AY4 | |
| DQAPNSHVKYVWKML | 3846 | Q7Z7G8 | |
| HWKFPQEQNKMKPEF | 436 | P0C7I0 | |
| PKAMKSILDHLNWVF | 1391 | Q9UI33 | |
| KWPFFQEAQKLQAMH | 106 | Q05066 | |
| VFVNHMEEKPYKWNG | 231 | P17014 | |
| FIHSKEKPTMLQWIE | 2316 | Q70CQ2 | |
| FWDQPDNIAHMKAKG | 396 | Q9BY64 | |
| QPAWMNDSHKDQSKR | 86 | Q5VYS8 | |
| EAAHKWSLPEMVSKE | 56 | P17948 | |
| SMNEPKHGLALWEAK | 1906 | Q6N021 | |
| PDKREENDQSTHKWM | 221 | Q9ULM3 | |
| ECMWPQGVLVKHSKN | 376 | Q9GZU3 | |
| DPKEQWVKDAMQHLD | 76 | P78423 | |
| IDNTNLHAWEMKPYA | 116 | Q5TBK1 | |
| EMLPLLDHWNTQTKK | 1476 | Q86UW6 | |
| KIMNEHLYKQAWEAD | 1986 | P20929 | |
| EAWDKDKTQVHIMPD | 3211 | P20929 | |
| PKIMWSLHIAKVQSD | 3301 | P20929 |